Current
29.1×
5-Year Average
43.4×
All-Time High
707.3×
All-Time Low
2.8×
P/B Ratio daily chart for IDEXX Laboratories (IDXX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/B Ratio for IDEXX Laboratories (IDXX) from 2001 to 2025
| 2025 | $54.19B | $1.61B | 33.8× | +12.5× | |
| 2024 | $33.84B | $1.60B | 21.2× | -9.9× | |
| 2023 | $46.12B | $1.48B | 31.1× | -24.5× | |
| 2022 | $33.83B | $608.74M | 55.6× | -25.4× | |
| 2021 | $55.86B | $689.99M | 81.0× | +13.3× | |
| 2020 | $42.73B | $632.09M | 67.6× | -58.7× | |
| 2019 | $22.42B | $177.47M | 126.3× | — | |
| 2018 | $16.07B | −$9.51M | — | — | |
| 2017 | $13.67B | −$54.11M | — | — | |
| 2016 | $10.47B | −$108.35M | — | — | |
| 2015 | $6.62B | −$84.13M | — | — | |
| 2014 | $7.08B | $117.52M | 60.2× | +49.6× | |
| 2013 | $5.53B | $518.19M | 10.7× | +2.7× | |
| 2012 | $5.08B | $636.22M | 8.0× | +0.1× | |
| 2011 | $4.25B | $539.58M | 7.9× | +0.9× | |
| 2010 | $3.98B | $574.24M | 6.9× | +0.9× | |
| 2009 | $3.10B | $514.57M | 6.0× | +1.2× | |
| 2008 | $2.13B | $438.19M | 4.9× | -3.3× | |
| 2007 | $3.57B | $438.32M | 8.1× | +2.1× | |
| 2006 | $2.47B | $409.86M | 6.0× | -0.2× | |
| 2005 | $2.29B | $369.01M | 6.2× | +1.7× | |
| 2004 | $1.80B | $397.66M | 4.5× | +0.6× | |
| 2003 | $1.61B | $413.29M | 3.9× | +0.7× | |
| 2002 | $1.10B | $340.97M | 3.2× | +0.0× | |
| 2001 | $966.00M | $301.73M | 3.2× | — |
- 202533.8×
- 202421.2×
- 202331.1×
- 202255.6×
- 202181.0×
- 202067.6×
- 2019126.3×
- 2018—
- 2017—
- 2016—
- 2015—
- 201460.2×
- 201310.7×
- 20128.0×
- 20117.9×
- 20106.9×
- 20096.0×
- 20084.9×
- 20078.1×
- 20066.0×
- 20056.2×
- 20044.5×
- 20033.9×
- 20023.2×
- 20013.2×
About P/B Ratio at IDEXX Laboratories (IDXX)
IDEXX Laboratories (IDXX) P/B ratio is 29.1× as of June 5, 2026. The 5-year average is 43.4×. The sector median currently stands at 3.4×. The current ratio is at the 27th percentile of its own 10-year history.
IDEXX Laboratories (IDXX) historical P/B ratio has ranged from a low of 2.8× (2002) to a high of 707.3× (2015) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
IDEXX Laboratories P/B Ratio by Year
IDEXX Laboratories P/B Ratio 2025: 33.8×
IDEXX Laboratories (IDXX) P/B ratio in 2025 was 33.8×, expanded from 21.2× the prior year.
IDEXX Laboratories P/B Ratio 2024: 21.2×
IDEXX Laboratories (IDXX) P/B ratio in 2024 was 21.2×, contracted from 31.1× the prior year.
IDEXX Laboratories P/B Ratio 2023: 31.1×
IDEXX Laboratories (IDXX) P/B ratio in 2023 was 31.1×, contracted from 55.6× the prior year.
IDEXX Laboratories P/B Ratio 2022: 55.6×
IDEXX Laboratories (IDXX) P/B ratio in 2022 was 55.6×, contracted from 81.0× the prior year.
IDEXX Laboratories P/B Ratio 2021: 81.0×
IDEXX Laboratories (IDXX) P/B ratio in 2021 was 81.0×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of IDEXX Laboratories (IDXX), ranked by P/B ratio.
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric